| CAS: | 1191-85-1 | |
| 分子式: | C20H24O2 | |
| 分子量: | 296.40 | |
| 熔点: | 79-81℃ | |
| 英文名称: |
|
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||||||||||||||||||||||||||
| E938409 | MACKLIN | ETYA | ≥98% | 950元/1mg; 2000元/5mg; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||
储存:2-8°C,密封,干燥 状态:白色到棕褐色粉末 | |||||||||||||||||||||||||||||||||||||||||||||||||||
| E1768 | Sigma-Aldrich | 5,8,11,14-Eicosatetraynoic acid | ≥97% | 4220.92元/5 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||
产品说明 包装 5 mg in glass bottle 生化/生理作用 Eicosatetraynoic acid (ETYA) is a non-metabolizable analog of ω-6 arachidonic acid. ETYA is a strong activator of the human peroxisome proliferator-activated receptor α (PPARα). It acts as an inhibitor of lipoxygenases (LOX) and cyclooxygenases (COX). 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||
| 434741 | Sigma-Aldrich | ETYA-CAS 1191-85-1-Calbiochem | Inhibits arachidonic acid uptake and the activities of arachidonic acid specific and non-specific acyl-CoA synthetases. | 4923.29元/20 MG; | 咨询 | ||||||||||||||||||||||||||||||||||||||||||||||
产品说明 一般描述 Cell permeable. Inhibits arachidonic acid uptake and the activities of arachidonic acid specific and non-specific acyl-CoA synthetases. Inhibits phospholipase A2 (PLA2) and cytochrome P-450. Inhibits cyclooxygenase (ID50 = 8 µM), 5-lipoxygenase (ID50 = 10 µM), 12-lipoxygenase (ID50 = 300 nM), and 15-lipoxygenase (ID50 = 200 nM) in whole cells. Also acts as a potent modulator of Ca2+ entry into cells. Blocks monocyte binding in minimally-oxidized LDL in endothelial cells. Stimulates luteinizing hormone release from cultured pituitary cells. 包装 20 mg in Plastic ampoule 生化/生理作用 Cell permeable: yes 警告 Toxicity: Standard Handling (A) 重悬 Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C. 其他说明 Honda, H.M., et al. 1999. Arterioscler. Thromb. Vasc. Biol.19, 680. 法律信息 CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||||||||||||||||||||||||||